St. Jude, firing back, posts 377 Medtronic Quattro lead deaths

April 10, 2012 by MassDevice staff

St. Jude Medical fires back against the Heart Rhythm Journal's refusal to retract a study linking its recalled Riata defibrillator leads, posting a list of 377 deaths related to arch-rival Medtronic's Quattro lead.


The editor of the Heart Rhythm Society's journal is sticking to his guns and refusing to retract an article linking some 22 deaths with St. Jude Medical's (NYSE:STJ) recalled Riata defibrillator leads, despite the med-tech giant's insistence that the study contains fundamental factual errors.

St. Jude fired back, backing up a prior claim that the study vastly undercounted the number deaths related to arch-rival Medtronic's (NYSE:MDT) Quattro Secure leads, published all 377 of the records from an FDA database of adverse medical events.

St. Jude posted on its Riata recall website today all 377 Quattro deaths it culled from the FDA's database, calling on the study's author, prominent cardiologist Dr. Robert Hauser, to definitively stand behind the 62 deaths he noted in his paper and inviting Medtronic to review the findings for itself.

Sign up to get our free newsletters delivered straight to your inbox

Hauser's study of data from the FDA's MAUDE database listed 62 deaths, 5 lead-related, for the Quattro lead.